FundedIQ
Biotechnology

ADNTRO Genetics: Funding, Investors & Team (Sep 2026)

Genetic progress in recent years is only comparable to the advancements in the field of computer science. Our vision is to enable everyone to learn about their unique genetic code and inspire new ideas and scientific approaches. Since the completion of the human genetic code in 2003, the number of studies and sources of information on genetic markers, along with the scientific drive to better understand the genotype-phenotype has grown exponentially. In ADNTRO we help you navigate all present & future findings. Invest in your DNA – its for Life.

adntro.com LinkedIn Palma De Mallorca, Spain 1-10 employees
Biopharma Genetics Health Care Medical
Total raised
$1.1M
Rounds
1
Latest
Seed
Oct 2024

ADNTRO Genetics has raised $1.1M across 1 funding round on record, the most recent a Seed of $1.1M announced in Oct 2024.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

ADNTRO Genetics Company Profile and Key Stats

Total funding raised
$1.1M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$1.1M in Oct 2024
Employees
1-10
reported band
Headquarters
Palma De Mallorca, Spain

Latest funding round on record: Oct 2024.

ADNTRO Genetics Funding Rounds

Date
Round
Amount
Seed
$1.1M

ADNTRO Genetics Founders and Leadership Team

Name
Role
Contact
Adan Gonzalez Lopez
Founder

No contact details are on record for this team yet.

ADNTRO Genetics Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
1,054
$3.1M
16,664
$3.1M

ADNTRO Genetics' latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like ADNTRO Genetics in Biotechnology and Palma De Mallorca

Companies Similar to ADNTRO Genetics

Connecta Therapeutics is a biotechnology company that develops new treatments for unresolved medical needs of…

Undisclosed round $4.2M

iPremom is a healthcare technology company that develops molecular diagnostic solutions for the early…

Seed $17.4M

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological…

Undisclosed round $8.1M

Ona Therapeutics is a biotech company that specializes in the discovery and development of therapeutic…

Series B $86.6M

IMPETUX develops and markets patented technology to characterise the mechanical properties of living tissues…

Undisclosed round $2.9M

Molecular Gate refer to an innovative class of small-molecule drugs developed by Gate Bioscience. These drugs…

Seed $530k

Modern medicine fails because it studies life in static environments. 60Nd revolutionizes the field with…

Undisclosed round $2.9M

Devicare designs point-of-care medical devices that monitor, diagnose and treat chronic diseases. The…

Undisclosed round $1.4M

Universal Diagnostics S.A. (UDX) is a company in Spain that specializes in in-vitro diagnostics. Their focus…

Undisclosed round $34.9M

Phyture Biotech originated as a spin-off of the Faculty of Pharmacy at the University of Barcelona, founded…

Undisclosed round $2.3M

Polimerbio offers sanitary product design and development based on biocompatible polymers, particularly…

Undisclosed round $530k

Overture Life is a biotechnology company that specializes in developing automated technologies for assisted…

Undisclosed round $23.1M

ADNTRO Genetics Funding FAQs

What does ADNTRO Genetics do?

Genetic progress in recent years is only comparable to the advancements in the field of computer science. Our vision is to enable everyone to learn about their unique genetic code and inspire new ideas and scientific approaches. Since the completion of the human genetic code in 2003, the number of studies and sources of information on genetic markers, along with the scientific drive to better understand the genotype-phenotype has grown exponentially. In ADNTRO we help you navigate all present & future findings. Invest in your DNA – its for Life.

How much funding has ADNTRO Genetics raised?

ADNTRO Genetics has raised $1.1M across 1 round on record. The most recent is a Seed of $1.1M announced in Oct 2024.

When did ADNTRO Genetics last raise funding?

ADNTRO Genetics' most recent funding round on record is a Seed of $1.1M, announced in Oct 2024.

Who founded ADNTRO Genetics?

FundedIQ lists Adan Gonzalez Lopez (Founder) at ADNTRO Genetics.

Where is ADNTRO Genetics headquartered?

ADNTRO Genetics is based in Palma De Mallorca, Islas Baleares, Spain.

How many employees does ADNTRO Genetics have?

ADNTRO Genetics is in the 1-10 employee band.

How does ADNTRO Genetics' funding compare to other Biotechnology startups?

ADNTRO Genetics' latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's ADNTRO Genetics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ADNTRO Genetics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.